Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Brian A PettygroveCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717.ORCID 0000-0003-4205-9361
Tyler K NygaardDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.
Timothy R BorgognaCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717.ORCID 0000-0001-6611-0251
Natalia MalachowaLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Gauri GaurCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717.
Shannon E SaloPathogen Molecular Genetics Section, Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infection Diseases, National Institutes of Health, Bethesda, MD 20892.ORCID 0009-0007-4337-7077
Kyler B PallisterDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.
Owen BurroughsDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.ORCID 0000-0002-8274-8295
Cassandra RobinsonDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.
Annika GaoDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.ORCID 0009-0002-2890-3669
Daniel E SturdevantResearch Technologies Branch, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Stacy RicklefsResearch Technologies Branch, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.ORCID 0009-0006-0329-7796
Frank R DeLeoLaboratory of Bacteriology, Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.ORCID 0000-0003-3150-2516
Michael OttoPathogen Molecular Genetics Section, Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infection Diseases, National Institutes of Health, Bethesda, MD 20892.ORCID 0000-0002-2222-4115
Philip S StewartCenter for Biofilm Engineering, Montana State University, Bozeman, MT 59717.ORCID 0000-0001-7773-8570
Jovanka M VoyichDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717.
Funding
Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Ann Therese Bertagnolli · 2012 to 2026
$60.0M
Staphylococcal pathogenesisZIAAI000904 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI OTTO, MICHAEL · 2009 to 2025
$22.6M
Tracking and Evaluation CoreU54GM115371 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI HOPKINS, SCARLETT H · 2016 to 2020
$20.9M
Mechanisms of Staphylococcus aureus virulenceZIAAI001079 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2009 to 2025
$11.8M
Defining SaeR/S-dependent Neutrophil-S. aureus Interactions that Determine the Outcome of InfectionR01AI149491 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI NYGAARD, TYLER K, VOYICH, JOVANKA M · 2020 to 2024
$3.1M
How Do a Few Attached Staphylococcus aureus Bacteria Evade Innate Immunity to Initiate Biofilm Infection on an Implanted Medical Device?R56AI155692 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI STEWART, PHILIP S · 2021 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.